返回 
加入收藏
腾药热敷联合宫炎康颗粒治疗慢性盆腔炎的临床观察
x
请在关注微信后，向客服人员索取文件
| 篇名： | 腾药热敷联合宫炎康颗粒治疗慢性盆腔炎的临床观察 |
| TITLE： | |
| 摘要： | 目的：探讨腾药热敷联合宫炎康颗粒治疗慢性盆腔炎的临床疗效及安全性。方法：选取2015年7月－2016年6月我院门诊收治的慢性盆腔炎患者141例，按照随机数字表法分为对照组（65例）和观察组（76例）。对照组患者口服宫炎康颗粒9 g，bid；观察组患者在对照组基础上加用腾药热敷下腹部30 min，至凉为止，每日1次。两组患者均从月经期结束后第3天开始用药，连续治疗20 d。比较两组患者治疗前后的中医证候评分及局部体征评分及临床疗效，并记录两组患者的不良反应及复发情况。结果：治疗前，两组患者中医证候评分及局部体征评分比较，差异均无统计学意义（P＞0.05）；治疗后，两组患者中医证候评分、局部体征评分均显著降低，且观察组显著低于对照组，差异均有统计学意义（P＜0.05）。观察组患者临床总有效率为92.11％，显著高于对照组的70.77％；观察组患者复发率为2.99％，显著低于对照组的15.79％，差异均有统计学意义（P＜0.05）。两组患者均未见明显不良反应发生。结论：腾药热敷联合宫炎康颗粒治疗慢性盆腔炎疗效显著，能明显改善患者中医症候和局部症状，降低复发率，且安全性较好。 |
| ABSTRACT： | OBJECTIVE： To investigate clinical efficacy and safety of Teng medicine combined with Gongyankang granules in the treatment of chronic pelvic inflammatory disease （CPID）. METHODS： A total of 141 CPID outpatients were selected from our hospital during Jul. 2015-Jun.2016， other patients were divided into control group （65 cases） and observation group （76 cases） according to random number table. Control group was given Gongyankang granules 9 g orally， bid； observation group additionally received Teng medicine hot compress on lower abdomen for 30 min until it was cool， once a day， on the basis of control group. Both groups began the medication since third day after the menstrual period， for consecutive 20 d. TCM syndrome， local sign scores and clinical efficacies were compared between 2 groups before and after treatment， and the occurrence of ADR and recurrence were observed in 2 groups. RESULTS： Before treatment， there was no statistical significance in TCM syndrome scores or local sign scores between 2 groups （P＞0.05）. After treatment， TCM syndrome scores and local sign scores of 2 groups were decreased significantly， and the observation group was significantly lower than the control group， with statistical significance （P＜0.05）. Clinical total response of observation group were 92.11％， which were significantly higher than 70.77％ of control group， rate recurrence rate of observation group were 2.99％， which were significantly under than 15.79％ of control group，with statistical significance （P＜0.05）. No obvious ADR was found in 2 groups. CONCLUSIONS： Teng medicine hot compress combined with Gongyankang granules show significant efficacy for CPID， can improve TCM syndrome and local sign and reduce recurrence rate with good safety. |
| 期刊： | 2017年第28卷第26期 |
| 作者： | 薛小荣，胡斌，王惠川，王宝玲，李琼阁，寿晓嫒，和心依 |
| AUTHORS： | XUE Xiaorong，HU Bin，WANG Huichuan，WANG Baoling，LI Qiongge，SHOU Xiao’ai，HE Xinyi |
| 关键字： | 腾药；热敷；慢性盆腔炎；宫炎康颗粒 |
| KEYWORDS： | Teng medicine； Hot compress； Chronic of pelvic inflammatory disease； Gongyankang granules |
| 阅读数： | 263 次 |
| 本月下载数： | 1 次 |
* 注：未经本站明确许可，任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作！
